Gavilimomab (ABX-CBL), an IgM murine monoclonal antibody, targets CD147 on cell surfaces to induce complement-mediated cytotoxicity. It is utilized in the study of graft-versus-host disease (GVHD) [1].
CAS Number:
[244096-20-6]
* VAT and and shipping costs not included. Errors and price changes excepted